{
  "meta": {
    "timestamp": "2025-01-06T09:59:52.211016",
    "version": "1.0",
    "type": "search_analysis"
  },
  "companies": [
    {
      "company_name": "Dolby Laboratories Inc",
      "symbol": "DLB",
      "analysis": {
        "historical": {
          "risk_score": 50,
          "key_risks": [
            "Revenue dependence on licensing agreements",
            "Competition and technological obsolescence",
            "Legal and ethical concerns related to licensing and IP enforcement",
            "Market overhangs from sluggish box office performance and macroeconomic challenges"
          ],
          "controversies": [
            "Historical legal disputes, such as Scheiber v. Dolby Laboratories",
            "Potential regulatory scrutiny of licensing models"
          ],
          "environmental_issues": [
            "Commitment to achieving net-zero emissions by 2030"
          ],
          "social_issues": [
            "Emphasis on ethical practices, including anti-corruption policies and compliance with employment laws"
          ],
          "governance_issues": [
            "Potential lapses in ethical practices or compliance could harm reputation and financial standing"
          ],
          "recommendation": "caution",
          "confidence_score": 75
        },
        "evidence": {
          "sources": [
            {
              "url": "",
              "title": "Dolby Laboratories, Inc. - Financials - Annual Reports",
              "snippet": "At Dolby, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the 'unsubscribe' section below. If you experience any issues with this process, please contact us for further assistance.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Dolby Laboratories Inc Dolby Laboratories Inc licensing revenue risks",
              "retrieved_at": "2025-01-06T16:59:25.369927+00:00",
              "published_date": null,
              "source_hash": "60ac1e21d287dcec23ca997e5c63dacf"
            },
            {
              "url": "",
              "title": "Dolby Laboratories, Inc. - Dolby Laboratories Reports Fourth Quarter ...",
              "snippet": "Dolby Laboratories, Inc. (NYSE:DLB) today announced the company's financial results for the fourth quarter and fiscal year 2024. \"We are pleased with the progress we made in fiscal 2024,\" said Kevin Yeaman, President and CEO, Dolby Laboratories. \"As we enter fiscal 2025, we have strong momentum with Dolby Atmos and Dolby Vision, our imaging patent portfolio has gotten stronger with the GE ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Dolby Laboratories Inc Dolby Laboratories Inc licensing revenue risks",
              "retrieved_at": "2025-01-06T16:59:25.369992+00:00",
              "published_date": null,
              "source_hash": "4916c768fd786f4aa13c104844da8dba"
            },
            {
              "url": "",
              "title": "Dolby Laboratories Reports Third Quarter 2024 Financial Results",
              "snippet": "Dolby Laboratories, Inc. (NYSE:DLB) today announced the company's financial results for the third quarter of fiscal 2024. \"Our third quarter results were in line with expectations,\" said Kevin Yeaman, President and CEO, Dolby Laboratories. \"This quarter we continued to build momentum for the content available in Dolby Vision and Dolby Atmos, especially in sports, with viewers around the world ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Dolby Laboratories Inc Dolby Laboratories Inc licensing revenue risks",
              "retrieved_at": "2025-01-06T16:59:25.370003+00:00",
              "published_date": null,
              "source_hash": "7c5fa8f41d055b963268508d2fb38bba"
            },
            {
              "url": "",
              "title": "Dolby Laboratories, Inc. (DLB): history, ownership, mission, how it ...",
              "snippet": "How Dolby Laboratories, Inc. (DLB) Makes Money Revenue Composition As of the fiscal year ended September 29, 2023, Dolby Laboratories' revenue is predominantly derived from licensing, which accounts for 92% of total revenue, while products and services contribute 8%. ... The breakdown of licensing revenue by market for the fiscal year 2023 is ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Dolby Laboratories Inc Dolby Laboratories Inc licensing revenue risks",
              "retrieved_at": "2025-01-06T16:59:25.370007+00:00",
              "published_date": null,
              "source_hash": "7f08346cc58cc2c478e8cbca787f5e0c"
            },
            {
              "url": "",
              "title": "dlb-20210924 - SEC.gov",
              "snippet": "Cinema Industry Risks. Revenue from Dolby Cinema and cinema product sales is subject to the pace of construction or upgrade of screens, the advent of new or competing technologies, the willingness of movie studios to produce films in our Dolby Atmos and Dolby Vision formats, consumer trends, box-office performance generally, and other events or ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Dolby Laboratories Inc Dolby Laboratories Inc licensing revenue risks",
              "retrieved_at": "2025-01-06T16:59:25.370017+00:00",
              "published_date": null,
              "source_hash": "43c04b1ae235142389c20c8a15115fd5"
            },
            {
              "url": "",
              "title": "PDF",
              "snippet": "to physical hardware products. As reported in Dolby's Annual Report on Form 10-K for the fiscal year ended September 24, 2021, Dolby's Products and Services revenue for the fiscal year period comprised approximately 5% of reported revenues of $1.28 billion. Most of Dolby's hardware products are manufactured by contract manufacturers.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Dolby Laboratories Inc Dolby Laboratories Inc licensing revenue risks",
              "retrieved_at": "2025-01-06T16:59:25.370021+00:00",
              "published_date": null,
              "source_hash": "0e5864c157bfb05d8af727205d4b5f75"
            },
            {
              "url": "",
              "title": "PDF",
              "snippet": "from outside the United States. Geographic data for our licensing revenue is based on the location of our licensees headquarters. Products revenue is based on the destination to whi ch we ship our products, while services revenue is based on the location where services are performed. 3 Fiscal Year Ended Revenue September 26, 2014",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Dolby Laboratories Inc Dolby Laboratories Inc licensing revenue risks",
              "retrieved_at": "2025-01-06T16:59:25.370025+00:00",
              "published_date": null,
              "source_hash": "1bee548582cbc7d405601e342bce9965"
            },
            {
              "url": "",
              "title": "Dolby Laboratories: Patents Are Not Enough To Protect The Business",
              "snippet": "They have 4 main licensing models but for most of them, Dolby charges un upfront fee and subsequent royalties would depend on the volume of products using Dolby technologies. Licensing revenue ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Dolby Laboratories Inc Dolby Laboratories Inc regulatory scrutiny licensing fees",
              "retrieved_at": "2025-01-06T16:59:33.155929+00:00",
              "published_date": null,
              "source_hash": "47fdfe69d20f903055eb749f3cd0c949"
            },
            {
              "url": "",
              "title": "Dolby Laboratories, Inc. - Dolby Laboratories Reports Fourth Quarter ...",
              "snippet": "SAN FRANCISCO, Nov. 17, 2022 (GLOBE NEWSWIRE) - Dolby Laboratories, Inc. (NYSE:DLB) today announced the company's financial results for the fourth quarter and full year of fiscal 2022. \"We continue to make progress in bringing the Dolby experience to all the ways people enjoy their content,\" said Kevin Yeaman, President and CEO, Dolby Laboratories. \"While results came in below our expectations ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Dolby Laboratories Inc Dolby Laboratories Inc licensing revenue risks",
              "retrieved_at": "2025-01-06T16:59:25.370037+00:00",
              "published_date": null,
              "source_hash": "30502a19bbd5d6bd48e6ba914285a8fc"
            },
            {
              "url": "",
              "title": "Dolby Labs To Buy GE Licensing From GE Aerospace For $429 Mln Cash",
              "snippet": "(RTTNews) - Dolby Laboratories, Inc. (DLB) announced Thursday that it has entered into a definitive agreement to acquire GE Licensing, an intellectual property licensing business, from GE ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Dolby Laboratories Inc Dolby Laboratories Inc licensing revenue risks",
              "retrieved_at": "2025-01-06T16:59:25.370041+00:00",
              "published_date": null,
              "source_hash": "d73dc657cce4d5ee69c043587e76fe0e"
            },
            {
              "url": "",
              "title": "Dolby Laboratories Inc (DLB) Q4 2024 Earnings Call Highlights: Strong Growth in Dolby Atmos and ...",
              "snippet": "GE Licensing Contribution: Expected to contribute $55 million to total revenue in FY 2025. Dolby Laboratories Inc (NYSE:DLB) reported a 5% year-over-year increase in revenue for the quarter ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Dolby Laboratories Inc Dolby Laboratories Inc regulatory scrutiny licensing fees",
              "retrieved_at": "2025-01-06T16:59:36.605866+00:00",
              "published_date": "2024-11-20T00:00:00+00:00",
              "source_hash": "9af76ea2303a79fae61b337e1cb88a98"
            },
            {
              "url": "",
              "title": "Dolby's Q4 Earnings Surpass Estimates, Revenues Increase Y/Y",
              "snippet": "Dolby Laboratories, Inc DLB reported fourth-quarter ... while imaging patents are expected to grow around 15%, as the revenues gained from the GE Licensing acquisition are partly offset by tougher ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Dolby Laboratories Inc Dolby Laboratories Inc licensing revenue risks",
              "retrieved_at": "2025-01-06T16:59:27.618766+00:00",
              "published_date": "2024-11-20T14:44:00+00:00",
              "source_hash": "129d4c5710befa2e6f46bd482dc2613a"
            },
            {
              "url": "",
              "title": "Dolby Laboratories Non-GAAP EPS of $0.71, revenue of $288.8M",
              "snippet": "Dolby Laboratories press release (NYSE:DLB): Q3 Non-GAAP EPS of $0.71. Revenue of $288.8M (-3.2% Y/Y). Dolby is providing the following estimates for its fourth quarter of fiscal 2024: Dolby is ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Dolby Laboratories Inc Dolby Laboratories Inc licensing revenue risks",
              "retrieved_at": "2025-01-06T16:59:27.618782+00:00",
              "published_date": "2024-08-07T21:09:00+00:00",
              "source_hash": "7d9f7ce0d4844a01eef92f79a38c9603"
            },
            {
              "url": "",
              "title": "Dolby to Post Q4 Earnings: Here's What Investors Should Know",
              "snippet": "Dolby Laboratories Inc DLB is slated to report fourth ... box office performance remain overhangs on both licensing and products and services revenues. For the fourth quarter, DLB expects ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Dolby Laboratories Inc Dolby Laboratories Inc licensing revenue risks",
              "retrieved_at": "2025-01-06T16:59:27.618787+00:00",
              "published_date": "2024-11-18T15:10:00+00:00",
              "source_hash": "84ccbf94b55dc46b9f6b422d4a8c78b4"
            },
            {
              "url": "",
              "title": "Dolby Laboratories, Inc.: Dolby Laboratories Reports Fourth Quarter and Fiscal Year 2024 Financial Results",
              "snippet": "SAN FRANCISCO, Nov. 19, 2024 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE:DLB ... patent portfolio has gotten stronger with the GE Licensing acquisition, and we are excited about our opportunity ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Dolby Laboratories Inc Dolby Laboratories Inc regulatory scrutiny licensing fees",
              "retrieved_at": "2025-01-06T16:59:36.605855+00:00",
              "published_date": "2024-11-19T22:15:00+00:00",
              "source_hash": "c0d63a1ff06ed43323423506c03c7e46"
            },
            {
              "url": "",
              "title": "SCHEIBER v. DOLBY LABORATORIES INC (2002) | FindLaw",
              "snippet": "DOLBY LABORATORIES, INC., and Dolby Laboratories Licensing Corp., Defendants-Appellees. No. 01-2466. Decided: June 17, 2002 ... logically. Most statutes are the product of compromise, and compromises need not cut at the logical joints of a controversy. There just is no evidence that Congress in the 1988 amendment wanted to go or did go beyond ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Dolby Laboratories Inc Dolby Laboratories Inc labor practices controversies",
              "retrieved_at": "2025-01-06T16:59:29.160269+00:00",
              "published_date": null,
              "source_hash": "6b0767df23a8aa3e2876612097b14bd5"
            },
            {
              "url": "",
              "title": " Sound, Visual, & Display Technology - Dolby",
              "snippet": "Dolby Laboratories, Inc. and its subsidiaries (collectively, \"Dolby\") are committed to the highest ... of forced labor or human trafficking. Compliance with all applicable employment laws is a ... Anti-Corruption: As part of our wider commitment to ethical working practices, Dolby has in place, and actively enforces, our Anti-Corruption Policy ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Dolby Laboratories Inc Dolby Laboratories Inc labor practices controversies",
              "retrieved_at": "2025-01-06T16:59:29.160375+00:00",
              "published_date": null,
              "source_hash": "051f4ac42fd3f6ae8383e68009e2b8f4"
            },
            {
              "url": "",
              "title": " Scheiber v. Dolby Laboratories, Inc.",
              "snippet": "Dolby Laboratories, Inc. By Kelly Hershey Peter Scheiber, inventor of the \"surround sound\" stereo technology, agreed to license use of his patents to Dolby Laboratories, Inc., at a low ... Per se legal licensing practices include non-use of, and refusal to li y3 cense, the patented technology. Questionable practices include tying",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Dolby Laboratories Inc Dolby Laboratories Inc labor practices controversies",
              "retrieved_at": "2025-01-06T16:59:29.160393+00:00",
              "published_date": null,
              "source_hash": "2fa41a04f510639423cae4fdc76c5f0f"
            },
            {
              "url": "",
              "title": " Dolby Laboratories, Inc. Anticorruption Policy I. Purpose",
              "snippet": "Dolby Laboratories, Inc. and its subsidiaries (\"Dolby\") believe in conducting business around the globe in a legal and ethical manner. Dolby recognizes that cultural customs and practices differ from country to country; however, illegal or unethical conduct is never acceptable to Dolby, no matter how widespread the practice may be.",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Dolby Laboratories Inc Dolby Laboratories Inc labor practices controversies",
              "retrieved_at": "2025-01-06T16:59:29.160407+00:00",
              "published_date": null,
              "source_hash": "7913e8088614f20b753c4513e15cf7d3"
            },
            {
              "url": "",
              "title": " United States Court of Appeals",
              "snippet": "BRIEF OF AMICUS CURIAEDOLBY LABORATORIES, INC. IN SUPPORT OF NEITHER PARTY d GARRARD R. BEENEY AKASH M. TOPRANI SULLIVAN & CROMWELL LLP 125 Broad Street New York, New York 10004 (212) 558-4000 Counsel for Amicus Curiae Dolby Laboratories, Inc. August 30, 2019 Case: 19-16122, 08/30/2019, ID: 11416770, DktEntry: 84, Page 1 of 39",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Dolby Laboratories Inc Dolby Laboratories Inc labor practices controversies",
              "retrieved_at": "2025-01-06T16:59:29.160420+00:00",
              "published_date": null,
              "source_hash": "be7c915ba8deb3013319b92d6f9fb5a0"
            },
            {
              "url": "",
              "title": "Scheiber v. Dolby Laboratories, Inc. Case Brief for Law School",
              "snippet": "Dolby Laboratories, Inc. (2002) United States Court of Appeals for the Seventh Circuit - 293 F.3d 1014 Contributed by \ud83e\udd16LSDBot\ud83e\udd16 A company didn't want to pay for using someone's patented technology, even after the patent expired. ICRA Issue The issue is whether a company must pay royalties beyond the expiration of a patent and whether the ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Dolby Laboratories Inc Dolby Laboratories Inc labor practices controversies",
              "retrieved_at": "2025-01-06T16:59:29.160433+00:00",
              "published_date": null,
              "source_hash": "48509f88840510a56b1adef56c2e050d"
            },
            {
              "url": "",
              "title": " The Dolby Difference: Innovating with Purpose - s27.q4cdn.com",
              "snippet": "Ethics (Code) frames the way Dolby Laboratories, Inc. and its subsidiaries (Dolby) conduct business and articulates our shared values. In our pursuit to create immersive sight and sound experiences, we can encounter ethical dilemmas or gray-area questions that are not easily answered. There can be legal and regulatory requirements that when",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Dolby Laboratories Inc Dolby Laboratories Inc labor practices controversies",
              "retrieved_at": "2025-01-06T16:59:29.160452+00:00",
              "published_date": null,
              "source_hash": "35ee259571dbe67be995aa82b1ecc6a9"
            },
            {
              "url": "",
              "title": "Employment and Labor Law and Litigation - Ray ... - Ray Quinney & Nebeker",
              "snippet": "Ray Quinney & Nebeker has one of the largest employment and labor law practice groups in Utah. Our employment group is consistently ranked as one of the top employment and labor practice groups in the Chambers and Partners USA Guide.. We represent employers in all areas of the workplace, including wage and hour issues, discrimination, labor relations, ERISA (employee benefits), unemployment ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Dolby Laboratories Inc Dolby Laboratories Inc labor practices controversies",
              "retrieved_at": "2025-01-06T16:59:29.160465+00:00",
              "published_date": null,
              "source_hash": "016e02a709cd2d52058f5d61a3231ac6"
            },
            {
              "url": "",
              "title": " Dolby Laboratories, Inc.",
              "snippet": "DOLBY LABORATORIES, INC. (Exact name of registrant as specified in its charter) Delaware 001-32431 90-0199783 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) 1275 Market Street San Francisco, CA 94103-1410 (Address of principal executive offices) (Zip Code)",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Dolby Laboratories Inc Dolby Laboratories Inc labor practices controversies",
              "retrieved_at": "2025-01-06T16:59:29.160478+00:00",
              "published_date": null,
              "source_hash": "a284c8b2c94f7c46bf3938eb8a3e1bba"
            },
            {
              "url": "",
              "title": " Comments of Dolby Laboratories, Inc. Concerning the Competition and ...",
              "snippet": "Dolby also broadly and globally licenses its technology - including standards-essential patents (\"SEPs\"), software, trademarks, know-how, and other intellectual property - through a broad range of licensing practices and activities that are flexibly aligned to support Dolby's core businesses of cinema products, technology licensing,",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Dolby Laboratories Inc Dolby Laboratories Inc labor practices controversies",
              "retrieved_at": "2025-01-06T16:59:29.160489+00:00",
              "published_date": null,
              "source_hash": "67b77f31ff02a6071c374288b8fa25ef"
            },
            {
              "url": "",
              "title": "dlb-20210924 - SEC.gov",
              "snippet": "DOLBY LABORATORIES, INC. FORM 10-K. ... As with the two-tier licensing model, the combined implementation and system licensee pays us an initial licensing fee in addition to royalties as determined by the mix of Dolby technologies used, the nature of the implementations, and the volume of products using our technologies that are shipped, and is ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Dolby Laboratories Inc Dolby Laboratories Inc regulatory scrutiny licensing fees",
              "retrieved_at": "2025-01-06T16:59:33.155652+00:00",
              "published_date": null,
              "source_hash": "9c25a2b1b32441e7a4c63752c454810d"
            },
            {
              "url": "",
              "title": "PDF",
              "snippet": "Dolby Laboratories, Inc. (\"Dolby\") respectfully submits these comments in response to the Competition and Market Authority's (\"CMA\") request, dated January 25, 2023, concerning the draft Guidance on the application of the Chapter I prohibition in the ... Dolby's licensing incentives align with those of its partners because the ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Dolby Laboratories Inc Dolby Laboratories Inc regulatory scrutiny licensing fees",
              "retrieved_at": "2025-01-06T16:59:33.155790+00:00",
              "published_date": null,
              "source_hash": "1c5d598fa747a6edde4116d473d123bd"
            },
            {
              "url": "",
              "title": "Scheiber v. Dolby Laboratories, Inc. Case Brief for Law School",
              "snippet": "Dolby Laboratories, Inc. (2002) United States Court of Appeals for the Seventh Circuit - 293 F.3d 1014 Contributed by \ud83e\udd16LSDBot\ud83e\udd16 ... Dolby refuses to pay Scheiber what it owes under a licensing agreement because it claims the agreement is unlawful and unenforceable.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Dolby Laboratories Inc Dolby Laboratories Inc regulatory scrutiny licensing fees",
              "retrieved_at": "2025-01-06T16:59:33.155823+00:00",
              "published_date": null,
              "source_hash": "cd8614661259a9df6575a975e651bae2"
            },
            {
              "url": "",
              "title": "Dolby Laboratories Federal Litigation Filings - Company Legal Profiles",
              "snippet": "Dolby Laboratories Licensing Corporation et al v. Roku, Inc. Filed: August 1, 2024 as 5:2024cv04660 Court: California Northern District Court Defendant: Roku, Inc. Plaintiff: Dolby International AB, Dolby Laboratories Licensing Corporation",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Dolby Laboratories Inc Dolby Laboratories Inc regulatory scrutiny licensing fees",
              "retrieved_at": "2025-01-06T16:59:33.155878+00:00",
              "published_date": null,
              "source_hash": "db01d892a2f24b59f981d6a6bff79921"
            },
            {
              "url": "",
              "title": "Scheiber v. Dolby Laboratories, Inc.",
              "snippet": "Dolby Laboratories, Inc. By Kelly Hershey Peter Scheiber, inventor of the \"surround sound\" stereo technology, agreed to license use of his patents to Dolby Laboratories, Inc., at a low ... Licensing is generally considered pro-competitive, as 14. Herbert Hovenkamp et al., Intellectual Property & Antitrust 3-7 (2002). 15. Id. at 3-8. 16. Id. at 3-2.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Dolby Laboratories Inc Dolby Laboratories Inc regulatory scrutiny licensing fees",
              "retrieved_at": "2025-01-06T16:59:33.155905+00:00",
              "published_date": null,
              "source_hash": "8ee45780762e54896d9af9cc63c951cf"
            },
            {
              "url": "",
              "title": "Dolby Laboratories, Inc. - SEC.gov",
              "snippet": "Self-Regulatory Organization Rulemaking; Policy Statements; Petitions for Rulemaking; ... Fee Rate Advisories; Public Company Accounting Oversight Board Rulemaking; ... Dolby Laboratories, Inc. Release Number. 29492. SEC Issue Date. Oct. 27, 2010. Resources. Investment Company Act Order Rule: SEC Issued Version (pdf 16.11 KB) Last Reviewed or ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Dolby Laboratories Inc Dolby Laboratories Inc regulatory scrutiny licensing fees",
              "retrieved_at": "2025-01-06T16:59:33.155953+00:00",
              "published_date": null,
              "source_hash": "c844cf9d980804aee2094ce10d9d42d2"
            },
            {
              "url": "",
              "title": "Dolby Laboratories Licensing Corporation et al v. Roku, Inc.",
              "snippet": "Filing 29 MOTION for leave to appear in Pro Hac Vice ( Filing fee $ 328, receipt number ACANDC-19738469.) Filing fee previously paid on 8/16/2024 filed by Dolby International AB, Dolby Laboratories Licensing Corporation. ... Dolby Laboratories Licensing Corporation. (Attachments: #1 Certificate of Good Standing)(Reynolds, Michael) (Filed on 9 ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Dolby Laboratories Inc Dolby Laboratories Inc regulatory scrutiny licensing fees",
              "retrieved_at": "2025-01-06T16:59:33.155974+00:00",
              "published_date": null,
              "source_hash": "4690b2dbdddcc11dad6f87bdca0a3938"
            },
            {
              "url": "",
              "title": "LG Electronics, Inc. v. Dolby Laboratories, Inc. et al",
              "snippet": "Document filed by Dolby International AB, Dolby Laboratories, Inc., Dolby Laboratories Licensing Corporation, LG Electronics, Inc.. (Attachments: #1 Exhibit 1 to the Hausman Declaration, #2 Exhibit 2 to the Hausman Declaration, #3 Exhibit 3 to the Hausman Declaration)Motion or Order to File Under Seal: #34 .(Michael, William)",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Dolby Laboratories Inc Dolby Laboratories Inc regulatory scrutiny licensing fees",
              "retrieved_at": "2025-01-06T16:59:33.155998+00:00",
              "published_date": null,
              "source_hash": "ee1f13889f33983638e584e8461fa691"
            },
            {
              "url": "",
              "title": "Dolby Laboratories Inc | Reuters",
              "snippet": "Dolby Laboratories said on Thursday it was acquiring GE Licensing, an intellectual property business targeting the consumer digital media and electronics sectors, in a $429 million deal.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Dolby Laboratories Inc Dolby Laboratories Inc regulatory scrutiny licensing fees",
              "retrieved_at": "2025-01-06T16:59:33.156019+00:00",
              "published_date": null,
              "source_hash": "e6705798bd13e5bd7b5c3ae4d36dcdb4"
            },
            {
              "url": "",
              "title": "Dolby to Post Q4 Earnings: Here's What Investors Should Know",
              "snippet": "Dolby Laboratories Inc DLB is slated to report fourth-quarter ... and sluggish box office performance remain overhangs on both licensing and products and services revenues. For the fourth quarter ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Dolby Laboratories Inc Dolby Laboratories Inc regulatory scrutiny licensing fees",
              "retrieved_at": "2025-01-06T16:59:36.605809+00:00",
              "published_date": "2024-11-18T15:10:00+00:00",
              "source_hash": "95077c33bac122664a8f3555f0b74f11"
            },
            {
              "url": "",
              "title": "Dolby Laboratories Reports Strong Fiscal 2024 Performance",
              "snippet": "Dolby Laboratories ( (DLB)) has released its Q4 earnings. Here is a breakdown of the information Dolby Laboratories presented to its investors. Dolby Laboratories, Inc. is a global leader in audio ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Dolby Laboratories Inc Dolby Laboratories Inc regulatory scrutiny licensing fees",
              "retrieved_at": "2025-01-06T16:59:36.605874+00:00",
              "published_date": "2024-11-20T04:00:00+00:00",
              "source_hash": "ad3a9a317f7353a3166f0b464b525171"
            }
          ],
          "queries": [
            {
              "category": "financial_legal",
              "query": "Dolby Laboratories Inc licensing revenue risks",
              "rationale": "Investigate potential vulnerabilities in Dolby's revenue model due to dependence on licensing agreements",
              "priority": 1
            },
            {
              "category": "ethical_social",
              "query": "Dolby Laboratories Inc labor practices controversies",
              "rationale": "Assess any ethical concerns related to labor practices or workplace conditions",
              "priority": 2
            },
            {
              "category": "financial_legal",
              "query": "Dolby Laboratories Inc regulatory scrutiny licensing fees",
              "rationale": "Explore potential legal or regulatory challenges related to Dolby's licensing fee structures",
              "priority": 1
            }
          ]
        },
        "categorization": {
          "product_issues": [],
          "conduct_issues": [],
          "tags": [],
          "patterns": {}
        }
      },
      "metadata": {
        "analysis_timestamp": "2025-01-06T09:59:52.211032",
        "data_confidence": 75,
        "pattern_confidence": null
      }
    }
  ]
}